This protocol details early longitudinal imaging in the Parkinson’s progression markers initiative using [ 18F] AV-133 (PPMI AV-133 Prodromal Imaging).
No takes yet. Share an insight, caveat, or question.
Kenneth Marek (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: